News
-
-
PRESS RELEASE
BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes
BRAIN Biotech AG appoints Erik de Vries as Senior Business Development Director Enzymes. De Vries will transition from CEO of Enzymicals AG to BRAIN Biotech's Supervisory Board in 2025 -
-
PRESS RELEASE
BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets
BRAIN Biotech AG receives significant milestone payment of € 1.5 million and maintains progress towards year-end goals with strengthened cash position. Half-year results show revenue growth and improved EBITDA -
-
-
-
-
-
PRESS RELEASE
Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
BRAIN Biotech AG announces successful outcomes at the Annual General Meeting 2024, including approval of silent partnership with Hessen. CEO and Chairman express optimism for future growth and targets